This company listing is no longer active
Karo Pharma Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Wichtige Informationen
n/a
Dividendenausschüttung
n/a
Ausschüttungsquote
| Durchschnittlicher Branchenertrag | 2.2% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Gewinn pro Aktie | -€0.69 |
| Erwartete Dividendenrendite in 3 Jahren | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if KA6N's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if KA6N's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| Karo Pharma Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (KA6N) | n/a |
| Untere 25 % des Marktes (DE) | 1.6% |
| Markt Top 25 % (DE) | 4.7% |
| Branchendurchschnitt (Pharmaceuticals) | 2.2% |
| Analystenprognose in 3 Jahren (KA6N) | n/a |
Bemerkenswerte Dividende: Unable to evaluate KA6N's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate KA6N's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as KA6N has not reported any payouts.